PROCEPT BioRobotics Corporation Common Stock
PRCT
$27.69
-4.81%
PRCT
PROCEPT BioRobotics Corporation Common Stock
$27.69
Related headlines
PRCT price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on PROCEPT BioRobotics Corporation Common Stock's 12-month outlook, with a consensus price target around $36.00 and implied upside of +30.0% versus the current price.
Average Target
$36.00
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$22 - $36
Analyst target range
PRCT Technical Analysis
Beta
0.85
0.85x market volatility
Max Drawdown
-66.6%
Largest decline past year
52-Week Range
$19-$63
Price range past year
Annual Return
-55.4%
Cumulative gain past year
| Period | PRCT Return | S&P 500 |
|---|---|---|
| 1m | -3.5% | -0.1% |
| 3m | +2.1% | +11.4% |
| 6m | -23.1% | +8.2% |
| 1y | -55.4% | +22.7% |
| ytd | -10.0% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is PRCT Overvalued?
PE
-18.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.5x
Enterprise Value Multiple